Stanford University

Overview

The Ph.D. in Cancer Biology at Stanford University equips aspiring researchers with the knowledge and skills necessary to explore cancer at the molecular, genetic, cellular, and systems levels. This rigorous program emphasizes the connection between scientific insights and clinical applications, preparing students to contribute significantly to the understanding and treatment of cancer. Through a combination of structured coursework and hands-on research experiences, students are guided to develop their dissertation projects in close collaboration with faculty advisors.

What you'll study

Year 1 (Foundations + Research Rotations)

• Core coursework includes subjects such as quantitative methods, computational biology, genomics, and cancer systems biology.
• Research rotations in faculty laboratories allow students to explore various research areas and select a dissertation advisor.

Core courses (examples include)

• Statistical Methods
• Computational Analysis of Biological Information
• Analysis Techniques for the Biosciences Using MATLAB
• Programming Methodology
• Stem Cells, Immunology, and Regenerative Medicine
• Genomics
• Principles of Cancer Systems Biology
• Next Generation Sequencing and Applications

Dissertation phase

• Students develop and execute a dissertation research project after selecting a faculty advisor.
• Ongoing training includes advanced coursework, research milestones, and dissertation preparation.

Entry requirements

Applicants must possess, or anticipate obtaining prior to enrollment, a bachelor’s degree from an accredited U.S. college or university or an equivalent international degree. A Master’s degree is necessary only if the bachelor’s degree does not meet eligibility criteria.

GRE/GMAT and minimum GPA requirements are not fixed; some programs may request standardized test scores based on current departmental policies.

Career prospects

Graduates of the Ph.D. program in Cancer Biology can pursue diverse career opportunities in academia, research institutions, and the pharmaceutical or biotechnology industries. They are well-prepared to take on roles that involve conducting groundbreaking research, teaching, and developing innovative cancer therapies, contributing to advancements in healthcare and scientific knowledge.